Mohamed S Rashed Selected Research

succinylacetone

11/2008	Improved method to determine succinylacetone in dried blood spots for diagnosis of tyrosinemia type 1 using UPLC-MS/MS.
3/2006	Quantification of succinylacetone in urine of hepatorenal tyrosinemia patients by HPLC with fluorescence detection.
2/2006	Determination of succinylacetone in dried blood spots and liquid urine as a dansylhydrazone by liquid chromatography tandem mass spectrometry.
4/2005	Tandem mass spectrometric assay of succinylacetone in urine for the diagnosis of hepatorenal tyrosinemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mohamed S Rashed Research Topics

Disease

5	Tyrosinemias (Tyrosinemia) 12/2011 - 04/2005
3	Methylmalonic acidemia 01/2016 - 01/2006
2	Intellectual Disability (Idiocy) 07/2012 - 04/2005
2	Canavan Disease (Leukodystrophy, Spongiform) 05/2009 - 09/2007
2	Metabolic Diseases (Metabolic Disease) 01/2007 - 02/2006
2	Glutaric Acidemia I 01/2007 - 09/2005
1	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 01/2014
1	Propionic Acidemia 01/2014
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2014
1	Seizures (Absence Seizure) 07/2012
1	Microcephaly 07/2012
1	Dystonia (Limb Dystonia) 02/2011
1	Medium chain acyl CoA dehydrogenase deficiency 12/2010
1	Argininosuccinic Aciduria 03/2010
1	Peroxisomal Disorders (Peroxisomal Disorder) 08/2008
1	Muscle Weakness 04/2008
1	Renal Insufficiency (Renal Failure) 04/2008
1	Lysinuric Protein Intolerance 04/2008
1	MELAS Syndrome (Syndrome, MELAS) 01/2008
1	Stroke (Strokes) 01/2008
1	Hyperammonemia 12/2006
1	Quadriplegia (Spastic Quadriplegia) 02/2005
1	Muscle Spasticity (Spastic) 02/2005
1	Primary hyperoxaluria type 2 05/2002
1	Primary Hyperoxaluria (Oxaluria, Primary) 05/2002

Drug/Important Bio-Agent (IBA)

4	AcidsIBA 07/2012 - 09/2005
4	succinylacetoneIBA 11/2008 - 04/2005
2	PropionatesIBA 01/2016 - 01/2014
2	EnzymesIBA 01/2016 - 05/2009
2	Fatty Acids (Saturated Fatty Acids)IBA 12/2010 - 08/2008
2	N-acetylaspartate (N-acetyl aspartate)IBA 05/2009 - 09/2007
2	HHH syndromeIBA 01/2008 - 12/2006
1	Methylmalonyl-CoA MutaseIBA 01/2016
1	propionylcarnitineIBA 01/2014
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2014
1	SulfitesIBA 01/2014
1	Alanine (L-Alanine)FDA Link 07/2012
1	fumarylacetoacetase (fumarylacetoacetate hydrolase)IBA 12/2011
1	glutaric acidIBA 02/2011
1	3-hydroxyglutaric acidIBA 02/2011
1	Urea (Carbamide)FDA LinkGeneric 03/2010
1	aspartoacylaseIBA 05/2009
1	Phytanic AcidIBA 08/2008
1	pristanic acidIBA 08/2008
1	Carnitine (L-Carnitine)FDA LinkGeneric 04/2008
1	AmmoniaIBA 04/2008
1	Mitochondrial DNA (mtDNA)IBA 01/2008
1	benzofurazanIBA 01/2007
1	CarbonIBA 01/2007
1	Indicators and Reagents (Reagents)IBA 01/2007
1	homocitrullineIBA 12/2006
1	Biomarkers (Surrogate Marker)IBA 01/2006
1	Methylmalonic AcidIBA 01/2006
1	IsotopesIBA 04/2005
1	molybdopterin (molybdenum cofactor)IBA 04/2005
1	Sulfite OxidaseIBA 04/2005
1	glyceric acidIBA 05/2002

Therapy/Procedure

1	Lenses 02/2005